News – Page 822 – Endpoints News

Sobi's high-priority rare disease drug runs into a wall at EMA

5 years ago

Another four biotechs make Wall Street debut, raising $772M+ as IPO tidal wave crests

5 years ago

UCB touts another psoriasis win, this time over Cosentyx, as they look to break into packed market

5 years ago

Covid-19 roundup: Hydroxychloroquine fails again; Novavax lines up Warp Speed manufacturing partner

5 years ago

Christoph Westphal bags a $170M Fund V, slated to help breed some new biotechs at Longwood

5 years ago

Jeff Capello out the door as Michael McDonnell takes over Biogen's CFO post; Ron Bruehlman named interim CFO at IQVIA

5 years ago

FBI crackdown on China’s R&D espionage intensifies with new arrests and one fugitive in San Francisco

5 years ago

Could a patent ruling threaten Moderna’s Covid-19 vaccine?

5 years ago

AstraZeneca COPD drug finally gets OK from FDA, inching closer to GSK leader

5 years ago

PDUFA VII: FDA, industry preview their reauthorization wish lists

5 years ago

Turning cancer into a curable disease: Immunotherapy expert John Connolly picks up the reins as the new CSO of Sean ...

5 years ago

Ruxolitinib passes another PhIII test for graft-versus-host disease, a win for Incyte and Novartis

5 years ago

AMAG signs European partner as they hunt cash to get their lead drug through the clinic

5 years ago

This week's wave of biotech IPO players bumps up offerings and targets bigger harvests of cash

5 years ago

FDA lifts hold on CymaBay’s NASH drug, but the company may still leave the ailing field

5 years ago

The pharma world's champion patent wall builder is called out for their 'drip-feed' strategy to safeguard the next ...

5 years ago

Covid-19 roundup: UK adds $125M to build a new vaccine manufacturing center; Pfizer’s $2 billion contract sets ...

5 years ago

The outlier: 2020 may go down as one of the biggest economic meltdowns in US history — but biopharma is booming

5 years ago

Houston’s huge R&D hub takes center stage in feds’ campaign to clip China’s ties to researchers, IP theft

5 years ago

Fast follow: EQRx engineers $410M-plus worth of deals to CDK4/6, EGFR drugs

5 years ago

Genfit throws in the towel on NASH, exiting a tumultuous field full of bright market prospects and lethal R&D ...

5 years ago

Ayahuasca inspires another biotech startup at ATAI; Mylan TB drug gets green light in India

5 years ago

'Missing link': Bayer, Morningside help catapult a new kind of delivery tech to cell and gene therapy

5 years ago

Seer raises another $55M and finally reveals proteomic tech — can it hold up?

5 years ago

First page Previous page 819 820 821822823 824 825 Next page Last page